insights_auto
Kwa nini ANW imepungua kwa 10.26%?
Fahamu zaidichevron_right
ANW:FRA
Immuron Ltd
€ 0.018
arrow_downward
-10.26%(-0.0020) Siku 1
14 Okt, 22:00:00 GMT +2 · EUR
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya ANW...
Fungua
€ 0.02
Juu
€ 0.02
Chini
€ 0.02
Mtaji wa soko
9.35M
Wastani wa kiasi cha mauzo
904.00
Kiasi cha mauzo ya hisa
0.00
Juu kwa wiki 52
€ 0.04
Chini kwa wiki 52
€ 0.01
Idadi ya wafanyakazi
8
Fungua
€ 0.02
Juu
€ 0.02
Chini
€ 0.02
Mtaji wa soko
9.35M
Wastani wa kiasi cha mauzo
904.00
Kiasi cha mauzo ya hisa
0.00
Juu kwa wiki 52
€ 0.04
Chini kwa wiki 52
€ 0.01
Idadi ya wafanyakazi
8
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Stock Titan
·
siku 1 iliyopita
A travel-diarrhea pill showed 50% less severe diarrhea, but missed its main trial goals
TipRanks
·
siku 2 zilizopita
Immuron advances Travelan after Phase 2 data published in Nature journal
Wasifu
Immuron is a biotechnology company based in Melbourne, Australia. In 2008, the company changed its name to Immuron Limited, having previously operated as Anadis Limited.
Immuron is focused on antigen-primed and dairy-derived health products. Its proprietary technologies allow for rapid development of polyclonal antibody and other proteins-based solutions for a range of diseases. The company specialises in nutraceutical, pharmaceutical and therapeutic technology products for conditions such as oral and GI mucositis, avian influenza, E. coli travellers' diarrhoea and Anthrax containment.
In 2005, Anadis signed an agreement with Quebec's Baralex Inc. and Valeo Pharma Inc. for the distribution of Travelan, a product made by Anadis for the Canadian market. Wikipedia
Kuhusu Immuron Ltd
Afisa Mkuu Mtendaji (CEO)-
Wafanyakazi8
Lilianzishwa1994
Makao makuuBlackburn North, Victoria, Australia
Sekta-
Tovutiimmuron.com.au